Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-198333
Filing Date
2010-08-26
Accepted
2010-08-26 16:25:23
Documents
11
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 964014
2 THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED JUNE 17, 2010 dex1032.htm EX-10.32 75819
3 SUBSIDIARIES OF THE COMPANY. dex211.htm EX-21.1 2122
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM -- ERNST & YOUNG LLP dex231.htm EX-23.1 1787
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) dex311.htm EX-31.1 6191
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(A) dex312.htm EX-31.2 6463
7 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. dex321.htm EX-32.1 3179
8 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. dex322.htm EX-32.2 3410
9 GRAPHIC g74581g07b78.jpg GRAPHIC 60035
10 GRAPHIC g74581img_pg17a.jpg GRAPHIC 3447
11 GRAPHIC g74581img_pg17b.jpg GRAPHIC 5577
  Complete submission text file 0001193125-10-198333.txt   1159980
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12104 | Film No.: 101040968
SIC: 2835 In Vitro & In Vivo Diagnostic Substances